4DMedical (ASX:4DX) entered an agreement with the academic medical center, Cleveland Clinic, for the clinical use of CT:VQ, the company's non-contrast ventilation-perfusion imaging product, according to a Friday filing with the Australian bourse.
An introductory pricing period will apply for the first month before the start of full commercial terms, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments